Loading Pathway...
Error: Pathway image not found.
Hide
Pathway Description
Cocaine Norepinephrine Reuptake Inhibitor Action Pathway
Homo sapiens
Drug Action Pathway
Cocaine is a local anesthesia and vasoconstrictor that is clinically used during diagnostic proceedures or during surgery in or through the nasal cavity. It comes in drugs called Goprelto and Numbrino which comes as a nasal spray. In these clinical drugs it takes the form of cocaine hydrochloride. The illicit drug has the same effects. It primarily acts on sensory neurons in the nasal cavity, but also inhibits dopamine, serotonin, and norepinephrine re-uptake channels.
Cocaine inhibits the sodium-dependent noradrenaline channel which causes norepinephrine to accumulate in the synapse. The high concentration of norepinephrine readily activates both alpha adrenergic receptors in the smooth muscles of blood vessels. This, through the Gq signalling cascade, leads to vasoconstriction of blood vessels especially in the nose. This also causes higher heart rate and higher blood pressure, due to vasoconstriction, in the rest of the body as seen in the norepinephrine subpathway.
References
Cocaine Norepinephrine Reuptake Inhibitor Pathway References
Galli A, DeFelice LJ, Duke BJ, Moore KR, Blakely RD: Sodium-dependent norepinephrine-induced currents in norepinephrine-transporter-transfected HEK-293 cells blocked by cocaine and antidepressants. J Exp Biol. 1995 Oct;198(Pt 10):2197-212. doi: 10.1242/jeb.198.10.2197.
Pubmed: 7500004
Burchett SA, Bannon MJ: Serotonin, dopamine and norepinephrine transporter mRNAs: heterogeneity of distribution and response to 'binge' cocaine administration. Brain Res Mol Brain Res. 1997 Oct 3;49(1-2):95-102. doi: 10.1016/s0169-328x(97)00131-9.
Pubmed: 9387868
Zhao Y, Sun L: Perinatal cocaine exposure reduces myocardial norepinephrine transporter function in the neonatal rat. Neurotoxicol Teratol. 2004 May-Jun;26(3):443-50. doi: 10.1016/j.ntt.2004.01.011.
Pubmed: 15113605
Carrera MR, Meijler MM, Janda KD: Cocaine pharmacology and current pharmacotherapies for its abuse. Bioorg Med Chem. 2004 Oct 1;12(19):5019-30. doi: 10.1016/j.bmc.2004.06.018.
Pubmed: 15351386
Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M: DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. doi: 10.1093/nar/gkx1037.
Pubmed: 29126136
Highlighted elements will appear in red.
Highlight Compounds
Highlight Proteins
Enter relative concentration values (without units). Elements will be highlighted in a color gradient where red = lowest concentration and green = highest concentration. For the best results, view the pathway in Black and White.
Visualize Compound Data
Visualize Protein Data
Downloads
Settings